Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/067e7168-cebe-45f9-8666-2b4a34da7f50/

GS71

GSK plc
Chart
€22.41
Latest Week 2026-06-05
HealthcareDrug Manufacturers - GeneralLARGE
Snapshot 2026-06-07 · 0.0w · Fresh
0.77
OS Score
36.0%
Value
94.0%
Quality
75.0%
Momentum
9/9
F-Score
0.582
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
5 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
9.9%
◐
Veiled Value
Yes
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Noneyr
🌱
GARP
✗
🔄
Shareholder Yield
4.5%
💰
High Yield
✗
🚀
Momentum Leaders
12-1 21%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
36.0%ile
P/E
15.5×
P/S
2.7×
P/B
5.0×
E/P
0.0647
FCF Yield
0.045
EBITDA/EV
0.099
SH Yield
0.045
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
68.00000000
/100 — 1=cheapest
VC2 (Trending Value)
64.00000000
/100
VC3 (Buyback)
65.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
94.0%ile
ROE
0.327
ROA
0.093
Net Margin
0.178
Op Margin
0.257
GPA
0.379
Current
0.79
F-Score
9/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.041
Earn Growth
1.258
Stability
0.349
lower=better
Accruals
-0.030
lower=better
5yr Consist
Yes
ROE of 33% is exceptional. F-Score of 9/9 indicates strong fundamental improvement across multiple dimensions.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
75.0%ile
6M Return
9.9%
12M Return
28.2%
12-1 Mom
21.0%
Risk-Adj
0.71
Vol 252d
29.3%
Vol 60d
69.4%
↑ Expanding
Max DD 12M
-15.8%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 21% is very strong — a clear uptrend. Near-term vol (69%) is expanding vs long-term (29%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.77
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 79 peers
Sector Value %ile
41.2%
Sector Quality %ile
93.8%
P/E z-score
-0.47
P/B z-score
0.14
Sector Avg OS
49.0%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
MED MEDICLIN Aktiengesellschaft 99.0% 97.0% 83.0% 79.0%
DRW8 Drägerwerk AG & Co. KGaA 96.0% 93.0% 62.0% 78.0%
DRW3 Drägerwerk AG & Co. KGaA 95.0% 85.0% 62.0% 80.0%
AJ91 DocCheck AG 95.0% 82.0% 88.0% 70.0%
CBHD Coloplast A/S 94.0% 98.0% 91.0% 22.0%
M12 M1 Kliniken AG 93.0% 70.0% 89.0% 76.0%
BRM Bristol-Myers Squibb Company 92.0% 61.0% 98.0% 74.0%
NOV Novo Nordisk A/S 91.0% 98.0% 78.0% 20.0%
Factor Interactions
Quality Momentum — Expensive
Strong quality (94th) and momentum (75th) but expensive (36th value). Premium priced — watch for mean reversion.
Volatility Expanding
60-day vol (69%) significantly exceeds 252-day (29%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
57.1% avg (7 factors)
Quality
B
66.1% avg (7 factors)
Momentum
C
54.7% avg (4 factors)
Risk
B
67.8% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.770—1—
Value %ile0.360—0—
Quality %ile0.940—1—
Momentum %ile0.750—1—
F-Score9.000—1—
Confidence0.939—1—
Volatility0.293—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
15.46
Earnings Yield (E/P)
0.0647
Price / Sales
2.75
Price / Book
5.05
Price / Cash Flow
11.64
FCF Yield
4.5%
EBITDA / EV
9.9%
Sales Yield (1/P·S)
0.3101
Shareholder Yield
Div + net buyback / mktcap
4.5%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
32.7%
Return on Assets
9.3%
Net Margin
17.8%
Operating Margin
25.7%
Gross Profit / Assets
Novy-Marx GPA
37.9%
Current Ratio
0.79
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.030
External Financing
Net issuance — lower=better
0.023
MomentumPrice trend strength over different horizons
6M Return
9.9%
12M Return
28.2%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
21.0%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.71
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
4.1%
Earnings Growth (YoY)
125.8%
Earnings Stability (CV)
Lower = more stable
0.349
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
9
Dividend Yield
2.9%
Buyback Yield
1.6%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
68
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
64
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
65
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
Yes
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity